![]() |
市场调查报告书
商品编码
1813454
犬类微生物组饮食市场预测(至 2032 年):按产品类型、配方、生命阶段、分销管道、最终用户和地区进行的全球分析Canine Microbiome Diet Market Forecasts to 2032 - Global Analysis By Product Type, Formulation, Life Stage, Distribution Channel, End User and By Geography |
根据 Stratistics MRC 的数据,全球犬类微生物组饮食市场预计在 2025 年达到 3,180 万美元,到 2032 年将达到 5,970 万美元,预测期内的复合年增长率为 9.4%。
犬类微生物组饮食是一种营养方法,旨在支持和优化爱犬的肠道微生物组。它强调以动物性蛋白质和健康脂肪为主,以物种适宜、加工程度最低的食物为主,同时限制碳水化合物和人工添加剂的摄取。该饮食旨在增加微生物多样性,改善消化功能,增强免疫功能,并减少发炎。透过与爱犬祖先的饮食保持一致,它能够促进肠道菌群平衡,从而促进整体健康,增强对代谢和胃肠道疾病的抵抗力。
宠物的人性化、健康意识和兽医意识的提高
人们日益意识到肠道健康与免疫力、行为和慢性疾病之间的关联,这推动了针对微生物组的饮食需求。兽医越来越多地推荐富含益生菌的配方和个人化营养计划,这些产品也已获得临床验证。微生物组定序和粪便检验的创新使得个人化干预措施成为可能,进一步推动了市场应用。宠物健康与科学检验的融合正在为成长奠定坚实的基础。
消费者怀疑论与教育不平等
由于对肠道微生物组及其在犬类健康中的作用了解有限,消费者不愿放弃传统宠物食品。缺乏标准化的标籤和不一致的产品宣传进一步加剧了消费者的决策难度。此外,微生物组相互作用的科学复杂性使其难以用简单的术语进行沟通,阻碍了其大规模普及。如果没有针对性的教育宣传活动和透明的产品沟通,市场渗透率很可能仍限于小众市场。
透过电子商务和DTC管道扩张
电商和DTC模式让品牌能够突破传统零售的限制,提供个人化、订阅式的微生物组饮食。这些管道有助于资料收集,使企业能够根据客户回馈和宠物健康状况改进配方。线上平台也支持教育内容,有助于填补知识空白并建立信任。随着消费者对便利性和客製化的需求日益增长,数位优先策略正在释放新的收益来源并加速市场扩张。
与传统宠物食品品牌的竞争
现有的宠物食品製造商正以激进的定价和广泛的分销网络进军功能性营养领域,这对利基微生物组饮食供应商构成了挑战。这些传统品牌通常拥有强大的品牌认知度和消费者忠诚度,这使得新兴企业难以脱颖而出。此外,一些传统产品正被重新包装,并宣称含有肤浅的益生菌成分,这削弱了科学配方的微生物组饮食的价值。
疫情改变了宠物饲养习惯,提高了宠物拥有率,也增强了人们对宠物健康的关注。由于疫情封锁导致兽医就诊减少,饲主主人转向居家健康解决方案,包括预防性营养和微生物组饮食。虽然供应链中断最初影响了原材料采购和产品供应,但线上宠物护理产品购买量的激增抵消了这些挑战。这场危机也加速了人们对免疫力增强配方的兴趣,这与微生物组饮食的核心益处相符。
预计功能性狗粮市场在预测期内将占最大份额
功能性狗粮市场预计将在预测期内占据最大市场份额,这得益于其广泛的吸引力和已证实的健康益处。这些产品通常添加益生元、益生菌和后生元,以支持消化平衡、免疫功能和营养吸收。该市场受益于临床研究和兽医建议的进步,成为注重健康的饲主的可靠选择。功能性食品针对过敏、肥胖和焦虑等特定情况量身定制,扩大了其效用。
预计预测期内粉末、咀嚼物和零食部分将以最高的复合年增长率成长。
由于便利性、偏好和精准投放,预计粉末、咀嚼和零食细分市场将在预测期内实现最高成长率。这些形式可以精确地添加支持微生物的成分,并且通常比传统的粗磨食物更容易管理。封装和掩味遮罩的创新正在提高宠物对产品的接受度,饲主也欣赏这种将补充剂灵活地添加到现有饮食中的灵活性。
受宠物拥有量成长、都市化和可支配收入成长的推动,预计亚太地区将在预测期内占据最大的市场份额。中国、日本和韩国等国家对高端宠物营养品(包括微生物强化饲料)的需求正在激增。该地区的企业正在投资本地生产和根据当地文化量身定制的配方,而全球品牌则透过策略合作伙伴关係扩大其影响力。兽医基础设施正在改善,宣传宣传活动也势头强劲,为市场扩张创造了肥沃的土壤。
预计北美在预测期内将呈现最高的复合年增长率,这得益于其先进的兽医护理、高昂的宠物医疗保健支出以及浓厚的宠物健康文化。该地区拥有多家专注于微生物组科学的生物技术新兴企业和研究机构,推动产品创新和临床检验。消费者对透明度、永续性和实证营养的要求日益提高,这与微生物组饮食的概念相符。法律规范也在不断发展,以支持功能性声明,鼓励投资和产品多样化。
According to Stratistics MRC, the Global Canine Microbiome Diet Market is accounted for $31.8 million in 2025 and is expected to reach $59.7 million by 2032 growing at a CAGR of 9.4% during the forecast period. Canine Microbiome Diet is a nutritional approach designed to support and optimizes the gut microbiota in dogs. It emphasizes species-appropriate, minimally processed foods primarily animal proteins and healthy fats while limiting carbohydrates and artificial additives. This diet aims to enhance microbial diversity, improve digestion, strengthen immune function, and reduce inflammation. By aligning with the canine ancestral diet, it fosters eubiosis, a balanced microbial state that promotes overall health and resilience against metabolic and gastrointestinal disorders
Pet humanization, health awareness and growing veterinary recognition
Rising awareness of gut health and its link to immunity, behavior, and chronic conditions is driving demand for microbiome-targeted diets. Veterinarians are increasingly recommending probiotic-rich formulations and personalized nutrition plans, validating the clinical relevance of these products. Innovations in microbiome sequencing and fecal testing are enabling tailored interventions, further boosting market adoption. The convergence of pet wellness and scientific validation is creating a robust foundation for growth.
Consumer skepticism and education gap
Limited understanding of gut flora and its role in canine health contributes to hesitation in switching from conventional pet food. The lack of standardized labeling and inconsistent product claims further complicates consumer decision-making. Additionally, the scientific complexity of microbiome interactions is difficult to communicate in simple terms, creating a barrier to mass adoption. Without targeted educational campaigns and transparent product communication, market penetration may remain confined to niche segments.
Expansion in E-commerce and direct-to-consumer (DTC) channels
E-commerce and DTC models allow brands to bypass traditional retail constraints and offer personalized subscription-based microbiome diets. These channels facilitate data collection, enabling companies to refine formulations based on customer feedback and pet health outcomes. Online platforms also support educational content, helping bridge the knowledge gap and build trust. As consumers increasingly seek convenience and customization, digital-first strategies are unlocking new revenue streams and accelerating market reach.
Competition from traditional pet food brands
Established pet food manufacturers are entering the functional nutrition space with aggressive pricing and broad distribution networks, posing a challenge to niche microbiome diet providers. These legacy brands often have stronger brand recognition and consumer loyalty, making it difficult for emerging players to differentiate. Additionally, some conventional products are being rebranded with superficial probiotic claims, diluting the perceived value of scientifically formulated microbiome diets.
The pandemic reshaped pet ownership dynamics, with increased adoption rates and heightened attention to pet health. As veterinary visits declined due to lockdowns, owners turned to preventive nutrition and at-home wellness solutions, including microbiome-supportive diets. Supply chain disruptions initially affected ingredient sourcing and product availability, but the surge in online pet care purchases offset these challenges. The crisis also accelerated interest in immunity-boosting formulations, aligning with the core benefits of microbiome diets.
The functional dog food segment is expected to be the largest during the forecast period
The functional dog food segment is expected to account for the largest market share during the forecast period due to its broad appeal and proven health benefits. These products often incorporate prebiotics, probiotics, and postbiotics to support digestive balance, immune function, and nutrient absorption. The segment benefits from growing clinical research and veterinary endorsement, making it a trusted choice among health-conscious pet owners. Functional diets are also being tailored to address specific conditions such as allergies, obesity, and anxiety, expanding their utility.
The powders, chews & treats segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the powders, chews & treats segment is predicted to witness the highest growth rate driven by convenience, palatability, and targeted delivery. These formats allow for precise dosing of microbiome-supportive ingredients and are often easier to administer than traditional kibble. Innovations in encapsulation and flavor masking are improving product acceptance among pets, while owners appreciate the flexibility of integrating supplements into existing diets.
During the forecast period, the Asia Pacific region is expected to hold the largest market share fueled by rising pet ownership, urbanization, and growing disposable incomes. Countries like China, Japan, and South Korea are witnessing a surge in demand for premium pet nutrition, including microbiome-enhancing diets. Regional players are investing in local manufacturing and culturally tailored formulations, while global brands are expanding their footprint through strategic partnerships. Veterinary infrastructure is improving, and awareness campaigns are gaining momentum, creating fertile ground for market expansion.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR attributed to advanced veterinary care, high pet healthcare spending, and a strong culture of pet wellness. The region is home to several biotech startups and research institutions focused on microbiome science, driving product innovation and clinical validation. Consumers are increasingly seeking transparency, sustainability, and evidence-based nutrition, which aligns with the ethos of microbiome diets. Regulatory frameworks are also evolving to support functional claims, encouraging investment and product diversification.
Key players in the market
Some of the key players in Canine Microbiome Diet Market include Purina, Hill's Pet Nutrition, Inc., ADM (Archer Daniels Midland), AnimalBiome, Inc., CanBiocin Inc., NomNomNow Inc., Royal Canin, Iams (Spectrum Brands Holdings), Kemin Industries, Lallemand Inc., Cargill, Incorporated, Chr. Hansen Holding A/S, Evonik Industries AG, Novozymes A/S, Zoetis Inc., and Vetoquinol.
In July 2025, CanBiocin Inc. and Lesaffre published a joint press release in July 2025 announcing an expanded partnership with CanBiocin to broaden presence in the companion-animal care market. The collaboration is intended to expand distribution and commercial reach for CanBiocin's species-specific probiotic solutions.
In July 2025, Lallemand announced the acquisition of enzyme specialist Solyve (Switzerland) in July 2025 to reinforce its microbial and enzyme capabilities. The move expands Lallemand's enzyme portfolio and CDMO capabilities for food, feed and biotech customers.
In June 2025, Royal Canin announced the launch of "Royal Canin Fresh Health Nutrition" in mid-June 2025 as a gently cooked line tailored to specific health needs across life stages. The launch positions Royal Canin's first gently cooked offering as an innovation in tailored pet nutrition for health outcomes.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.